FDA Import Refusal SCS-2184105-4/11/5 — Ipca Laboratories Limited
The FDA refused shipment SCS-2184105-4/11/5 from Ipca Laboratories Limited (India) on July 15, 2022. The refused product falls under Drugs and Biologics — METHOTREXATE (ANTI-NEOPLASTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- July 15, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ICA31 METHOTREXATE (ANTI-NEOPLASTIC)
- Charges
- 75